In a landmark event, the UK has become the first country in Europe to announce the birth of a child using mitochondrial donation treatment (MDT). The procedure was carried out to prevent the passing on of a serious genetic condition that causes heart, liver, and brain damage in children. The successful birth marks a major breakthrough in the fight against inherited genetic disorders and could potentially offer hope to many families.
Mitochondrial diseases are caused by mutations in the DNA of the mitochondria, which are tiny organelles inside cells that produce energy. These mutations are passed down from the mother, as only egg cells contain mitochondria. MDT is a technique that aims to replace faulty mitochondria in the mother’s egg with healthy mitochondria from a donor, resulting in a fertilized egg with genetic material from three people: the mother, the father, and the donor.
The technique was first introduced in the UK in 2015, but the use of MDT was only allowed in very specific cases, where the mother was at high risk of passing on a severe mitochondrial disease. The first successful birth using the technique was announced in 2016 in the US.
The latest birth is a testament to the efficacy of MDT in preventing genetic diseases from being passed on to children. The newborn was born healthy, and while the mother and father’s DNA make up the majority of the genetic material, the donor’s contribution is essential for the prevention of mitochondrial disease. The small amount of donor DNA will not affect the child’s physical or intellectual characteristics, as these are primarily determined by nuclear DNA from the mother and father.
The technique has been hailed as a significant milestone in the fight against genetic diseases. Mitochondrial diseases can be fatal and have a range of symptoms, from muscle weakness to heart disease, and blindness. There are currently no cures for these conditions, and treatment is often limited to managing symptoms. Many families who have lost children to these diseases see MDT as a promising option to have a healthy child.
However, the technique has been controversial due to ethical concerns around the creation of embryos with DNA from three people. Critics argue that the technique could lead to the creation of so-called “designer babies,” where genetic material is selected to enhance desirable traits.
Read more: Life-saving change: Breast cancer screenings now recommended at 40
The Human Fertilisation and Embryology Authority (HFEA) regulates the use of MDT in the UK and has strict guidelines in place to ensure that the technique is used only in cases where there is a significant risk of mitochondrial disease. The HFEA also requires that families receiving MDT undergo counseling to ensure that they are aware of the potential risks and benefits of the technique.
The successful use of MDT in the UK offers hope to families who are affected by mitochondrial diseases. However, the technique remains controversial, and it is important to continue the discussion around the ethical implications of creating embryos with genetic material from three people. As the field of genetics continues to advance, it is essential to balance scientific progress with ethical considerations to ensure that genetic technology is used for the betterment of humanity.